Web site is worth a read
https://neuroscientific.com/our-science/
Biopharmaceutical innovation and world class R&DNSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II).EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.
EmtinB is currently being developed as a treatment for neurodegenerative dementia and Alzheimer’s disease, and degenerative conditions of the optic nerve.
Web site is worth a...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.004(7.69%) |
Mkt cap ! $6.941M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 4.8¢ | $18.39K | 377.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 90 | 1 |
View Market Depth
| Last trade - 15.36pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.004 ( 7.69 %) |
||||
| Open | High | Low | Volume | ||
| 4.8¢ | 4.9¢ | 4.8¢ | 91010 | ||
| Last updated 13.28pm 26/04/2024 ? | |||||
| NSB (ASX) Chart |